Lonza Group AG against Teva Pharmaceutical Industries Limited — live side-by-side technical comparison.
Prices as of 2026-09-23T15:30:29+00:00 UTC · updates daily
TEVA leads 3 of the 5 windows we measure — over 1 month LONN.SW is -4.4% and TEVA +5.6%; over year to date LONN.SW is +4.5% and TEVA +25.0%.
| LONN.SW | TEVA | |
|---|---|---|
| Price | $561.80 | $39.01 |
| 1 day | -0.2%lead | -1.3% |
| 5 days | +4.3%lead | +1.2% |
| 1 month | -4.4% | +5.6%lead |
| 6 months | +20.2% | +35.6%lead |
| Year to date | +4.5% | +25.0%lead |
| 52-week position | 75% of range | 92% of range |
| 52-week range | $454.60–$597.80 | $18.21–$40.79 |
| vs 50-day average | below $564.23 | above $35.79 |
| vs 200-day average | above $530.05 | above $33.32 |
| RSI (14) | 38 | 59 |
| Next earnings | 2026-01-28 | 2026-11-03 |
LONN.SW trades at $561.80, below its 50-day average of $564.23, and above the 200-day at $530.05. It sits at 75% of its 52-week range ($454.60–$597.80); 14-day RSI is 38, in neutral territory; an average session moves it about 1.9%. For levels, the first level overhead is $564.23 (0.4% away) and the first support below is $554.70 (1.3% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
TEVA trades at $39.01, above its 50-day average of $35.79, and above the 200-day at $33.32. It sits at 92% of its 52-week range ($18.21–$40.79); 14-day RSI is 59, in neutral territory; an average session moves it about 3.3%. For levels, the first level overhead is $40.00 (2.5% away) and the first support below is $35.79 (8.2% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TEVA is the more volatile of the two — an average session moves it 3.3% against 1.9% for LONN.SW, so an identical position size carries roughly 1.7× the daily risk.
The comparison turns on those levels: LONN.SW clearing $564.23 or losing $554.70; TEVA clearing $40.00 or losing $35.79. Until one of them gives way, the relative reading above stands.